Lipids & metabolic liver disease
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
Recommendations
As issued by the authors
Screen for liver fibrosis and risk stratify people with prediabetes or T2D, in particular if obesity is also present
Broad adoption of screening for liver fibrosis as a new standard of care
Original publication
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care. Published 28 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →